drugset / Trial / NCT01915979
Effect of Plasma Rich in Growth Factors in Rotator Cuff Tendinopathy
Phase 3
Completed
84 enrolled
Fundacion para la Investigacion Biomedica del Hospital Universitario Principe de Asturias
RandomizedParallel-groupSingle-blindTreatment
Summary
The overall objective of the study is to assess the effectiveness of the treatment of degenerative rotator cuff tendinopathy using the application of plasma rich in growth factors (PRGF). Main objective: To show more effectiveness after 6 months of treatment with PRGF, with an improvement in the reference test of more than 15% compared to the treatment with corticosteroids. Secondary objective: * To assess the efficacy of the treatment after 12 months. * Quantification of platelet levels in patients treated with plasma rich in growth factors and its correlation with the clinical effect.
Timeline
- Start
- 2014-02
- Primary completion
- 2015-05
- Completion
- 2016-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Bethametasone | Other / unclassified | 2 ml | Other |
| Subject | Plasma rich in growth factors | Other / unclassified | 6 ml | Other |
| Subject | Plasma rich in growth factors | Other / unclassified | 8 ml | Other |